The Elecsys beta-amyloid (1-42) and Elecsys total-tau CSF assays (used as a tTau/Abeta42 ratio) are for use in adults ages 55 and older being evaluated for cognitive issues.
A new study and a meta-analysis provide more evidence that patients with large ischemic strokes and a significant amount of brain tissue damage may still benefit from thrombectomy.
Both coronary plaque burden and the rate of plaque progression are increased in patients with high Lp(a) levels, potentially explaining the link with higher CV risk, new findings suggest.
Prophylactic use of antiemetic, antipyretic, or antibiotic drugs in older patients with acute stroke did not reduce the risk of a poor functional outcome in the PRECIOUS trial.